MEDY TOX INC has a total of 51 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Republic of Korea, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, foods and drinks and organic fine chemistry are DA VOLTERRA, BIOSPECIFICS TECH CORP and BASIC ROBERT.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 9 | |
#2 | United States | 8 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | China | 5 | |
#5 | Australia | 4 | |
#6 | WIPO (World Intellectual Property Organization) | 4 | |
#7 | Singapore | 3 | |
#8 | Brazil | 2 | |
#9 | Canada | 2 | |
#10 | Japan | 2 | |
#11 | Mexico | 2 | |
#12 | Colombia | 1 | |
#13 | Hong Kong | 1 | |
#14 | Hungary | 1 | |
#15 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Organic fine chemistry | |
#4 | Biotechnology | |
#5 | Macromolecular chemistry and polymers | |
#6 | Environmental technology | |
#7 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Enzymes | |
#4 | Specific use of cosmetics | |
#5 | Microorganisms | |
#6 | Peptides | |
#7 | Climate change adaptation technologies | |
#8 | Compounding processes | |
#9 | Fermentation | |
#10 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Yang Gi Hyeok | 39 |
#2 | Jung Hyun Ho | 39 |
#3 | Rhee Chang Hoon | 31 |
#4 | Kim Hack Woo | 26 |
#5 | Kim Sung Bum | 18 |
#6 | Baek Seung Hwan | 16 |
#7 | Woo Hee Dong | 9 |
#8 | Yang Gi-Hyeok | 8 |
#9 | Kim Hyun Jee | 7 |
#10 | Jung Hyun-Ho | 6 |
Publication | Filing date | Title |
---|---|---|
EP3079714A1 | Long lasting effect of new botulinum toxin formulations | |
KR20160002207A | Pharmaceutical composition for treating osteoarthritis comprising botulinum toxin as an active ingredient and method for treating osteoarthritis in a patient | |
KR20160002256A | Pharmaceutical composition for treating osteoarthritis comprising cross-linked hyaluronan as an active ingredient and method for treating osteoarthritis in a patient | |
CA2831908A1 | Lyophilized preparation of botulinum toxin | |
KR20110091492A | Method of producing clostridium botulinum toxin using a media containing plant derived components and a flexible closed container | |
KR20130010973A | Method of prepairing crosslinked hyaluronic acid gel | |
KR20090005963A | Stable liquid composition of botulinum toxin | |
KR20090120222A | Method of producing clostridium botulinum toxin using a media containing plant derived components and a flexible closed container | |
KR100561163B1 | A process for the purification of clostridium botulinum neurotoxin type b using immnuno-affinity chromatography | |
KR20030060150A | Method for purifying clostridium botulinum a type toxin |